Three Stopping Points: What Positive Predictive Value Actually Measures

Faster Is Not Always Better: Why Mammography Audit Outcomes Need Time to Mature

Outcome-dependent audit metrics — CDR, PPV, sensitivity, specificity — can't be final until the one-year cancer outcome window closes. A case in your false-positive column today might be a true positive by year-end.

Your MQSA Audit Is Only as Credible as the Back Office Behind It

Mammography is the only field in U.S. medicine with a federally required diagnostic-safety system, in place since 1992. The September 10, 2024 MQSA Final Rule made that system inspectable. Whether a breast imaging practice honors it now depends on the back office.

FDA's New One-Day Inspectional Assessments: What Mammography Facilities Should Know

FDA launched a one-day inspectional assessment pilot in April 2026. Here is what mammography facilities need to know about MQSA implications, NAI outcomes, and continuous inspection readiness.

Protecting the Standard of Care: A Regulatory Risk Analysis of U.S. Breast Cancer Screening Infrastructure in 2026

A regulatory risk analysis of four convergent threats to U.S. breast cancer screening infrastructure in 2026 — USPSTF administrative disruption, MQSA enforcement continuity, the anti-over-medicalization cultural narrative, and their cascade interaction — with institutional response recommendations for breast imaging program leadership.

The Floor Is Shifting Under Mammography. Most Program Leaders Don't Know It Yet.

Four distinct forces are putting simultaneous pressure on breast imaging programs — USPSTF meeting disruptions, MQSA enforcement uncertainty, cultural headwinds against organized screening, and their combined cascading effect. A plain account of what is happening and where to focus.

The Breast MRI Medical Outcome Audit: What It Is, How It Works, and Why It Requires a Different Methodology Than Mammography

Breast MRI outcome auditing is not MQSA-mandated but is expected under ACR accreditation. This in-depth guide covers the three-stream audit architecture — screening, diagnostic, and preoperative MRI — with the ACR BI-RADS® two-tier benchmark framework, BCSC reference values, illustrative examples, and statistical interpretation guidance.

Preparing for an MQSA Inspection: What Mammography Facilities Need to Know

Annual MQSA inspections verify that certified mammography facilities meet federal quality standards. This guide covers exactly what FDA inspectors look for, how to organize your documentation, and how to prepare under the updated 2024 regulatory framework.

2024 MQSA Updates — Quick Reference Guide

The 2023 MQSA Final Rule (88 FR 15126) is the most significant update to mammography regulations since 1997. This quick reference guide covers every regulatory change in FROM/TO format — from new imaging assessment taxonomy and mandatory density notification to enforcement changes and personnel record rules.

Why Your Facility Needs Policy 1.02: Interpreting Physician Continuing Experience & Education

Policy 1.02 exists because initial credentialing is not a permanent guarantee of diagnostic competency. This guide explains the federal mandate under 21 CFR §900.12(a)(2), the operational challenge of tracking rolling qualification windows, inspection readiness, accountability structures, and the patient and facility protection stakes of a structured continuing qualification program.

Policy 1.02 — Interpreting Physician Continuing Qualifications

Mammography quality begins before a report is signed. It depends on whether the physician interpreting the examination remains qualified, experienced, educated, and authorized to perform independent mammography interpretation.

Why Your Facility Needs Policy 1.01: Interpreting Physician Initial Qualifications

MAMMOLOGIX Why Your Facility Needs Policy 1.01: Interpreting Physician Initial Qualifications A Guide for Mammography Facilities Committed to Compliance, Quality, and Patient Safety

Key FDA MQSA Regulatory Documents: A Practitioner's Reference

The foundational Federal Register rulings that govern mammography quality standards — from the original 1997 framework through the 2023 comprehensive update effective September 2024. Essential reading for anyone developing or auditing mammography policies.

Policy 1.01 — Interpreting Physician Initial Qualifications

Policy 1.01 establishes a clear, documented process for confirming that every physician who independently interprets mammograms for the facility meets applicable MQSA initial qualification requirements before independent interpretation begins.

Compliance without the jargon

A short, plain-language explainer that demystifies the compliance landscape for busy operators.

The Time Crunch in Mammography Audits: Why It Matters

In the fast-paced world of healthcare, there's a constant demand for "real-time" data. We want immediate outcomes and instant insights. While this works in some areas, mammography medical outcome audits are different.

The Future of Mammography Compliance: Insights into the FDA's New Framework

The United States Food and Drug Administration underwent a major reorganization starting October 1, 2024, which notably impacts many parts of the agency, including the Mammography Quality Standards Act (MQSA) Program.

Mammography Regulations Updates Released

Time to Get Ready for These Modernizations Coming to Your Mammography Practice Mammography remains a gold standard for the detection of breast cancer detection.